CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Evaluation of follow-up observation using human epididymis protein 4, a tumor marker, in patients with ovarian cancer
Masaya Uno, Rie Matsuo, Naoki Maezawa, Tomoyasu Kato
Obstet Gynecol Sci. 2023;66(4):290-299.   Published online June 28, 2023
DOI: https://doi.org/10.5468/ogs.23024

Excel Download

Evaluation of follow-up observation using human epididymis protein 4, a tumor marker, in patients with ovarian cancer
Masaya Uno, Rie Matsuo, Naoki Maezawa, Tomoyasu Kato
Obstetrics & Gynecology Science. 2023;66(4):290-299   Crossref logo
Link1 Link2 Link3
Serum human epididymis protein 4 vs. carbohydrate antigen 125 in ovarian cancer follow-up
Simona Ferraro, Cristina Robbiano, Nicoletta Tosca, Andrea Panzeri, Anna Maria Paganoni, Mauro Panteghini
Clinical Biochemistry. 2018;60:84-90   Crossref logo
Link1 Link2
Human Epididymis Protein 4 as a Diagnostic Marker of Ovarian Cancer and Its Reference Interval in Korean Population
Hee-Yeon Woo
Laboratory Medicine Online. 2016;6(1):12   Crossref logo
Link1 Link2 Link3 Link4
What is the appropriate use of CT in combination with tumor marker and medical examination findings in the follow-up of postoperative patients with ovarian cancer?
Hiroki Matsutani, Go Nakai, Satoe Fujiwara, Satoru Takahashi, Kazuhiro Yamamoto, Masahide Ohmichi, Keigo Osuga
. 2022;   Crossref logo
Link1 Link2
Erratum to: Human epididymis protein 4 expression positively correlated with miR-21 and served as a prognostic indicator in ovarian cancer
Tumor Biology. 2022;44(1):235-235   Crossref logo
Link1
Detection of serum human epididymis secretory protein 4 in patients with ovarian cancer using a label-free biosensor based on localized surface plasmon resonance
Jialing Yuan, Duan, Yang, Luo, Mingrong Xi
International Journal of Nanomedicine. 2012;2921   Crossref logo
Link1
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases
Jose M Escudero, Jose M Auge, Xavier Filella, Aureli Torne, Jaume Pahisa, Rafael Molina
Clinical Chemistry. 2011;57(11):1534-1544   Crossref logo
Link1 Link2
Evaluation of human epididymis protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA) as diagnostic tools of type I and type II epithelial ovarian cancer in Japanese women
Hiroyuki Fujiwara, Mitsuaki Suzuki, Nobuhiro Takeshima, Ken Takizawa, Eizo Kimura, Toru Nakanishi, Kyosuke Yamada, Hirokuni Takano, Hiroshi Sasaki, Koji Koyama, Kazunori Ochiai
Tumor Biology. 2014;36(2):1045-1053   Crossref logo
Link1 Link2 Link3 Link4
Evaluation of Tumor Immunity in Patients with Ovarian Cancer after Immunoscintigraphy in a Long-Term Follow-up
B. DONNERSTAG, R.P. BAUM, J.B. OLTROGGE, K. HENZEL, L. TRÄGER, G. HÖR
Hybridoma. 1995;14(2):191-197   Crossref logo
Link1
A Self-Calibrating IoT Portable Electrochemical Immunosensor for Serum Human Epididymis Protein 4 as a Tumor Biomarker for Ovarian Cancer
Valentina Bianchi, Monica Mattarozzi, Marco Giannetto, Andrea Boni, Ilaria De Munari, Maria Careri
Sensors. 2020;20(7):2016   Crossref logo
Link1